All terms in NCIT
| Label | Id | Description |
|---|---|---|
| ALK NM_004304.4:c.3522C>G | NCIT_C146864 | [A nucleotide substitution at position 3522 of the coding sequence of the ALK gene where cytosine has been mutated to guanine.] |
| How Often Bothered by Problems | NCIT_C107246 | [A question about how often an individual is or was bothered by problems.] |
| Ataxia-Telangiectasia-Like Disorder 1 | NCIT_C132224 | [An autosomal recessive condition caused by mutation(s) in the MRE11A gene, encoding double-strand break repair protein MRE11. It is characterized by progressive cerebellar degeneration resulting in ataxia and oculomotor apraxia.] |
| Feeling Nervous, Anxious or on Edge | NCIT_C107247 | [A question about whether an individual feels or felt nervous, anxious or on edge.] |
| Venous Segment | NCIT_C132225 | [A segment of a blood vessel that is part of the venous system.] |
| Not Able to Stop or Control Worrying | NCIT_C107248 | [A question about whether an individual is not or was not able to stop or control worrying.] |
| CDKN2A-p16 Negative | NCIT_C132226 | [Indicates that expression of the p16 form of CDKN2A has not been detected in a sample.] |
| CDKN2A-p16 Status | NCIT_C162803 | [An indication of whether CDKN2A-p16 expression has been detected in a sample.] |
| CDKN2A Negative | NCIT_C131787 | [Indicates that expression of CDKN2A has not been detected in a sample.] |
| Worrying too Much about Different Things | NCIT_C107249 | [A question about whether an individual worries or worried too much about different things.] |
| CREBBP Gene Mutation | NCIT_C132227 | [A change in the nucleotide sequence of the CREBBP gene.] |
| CREBBP Gene | NCIT_C26568 | [This gene plays a role in transcriptional regulation and in NF-kappa B signal transduction.] |
| Senokot-S | NCIT_C29450 | [A commercial combination preparation, by Purdue, containing a standardized senna concentrate and docusate sodium with laxative and stool softening activity. Senna concentrate consists of the anthraquinone glycosides sennosides extracted from senna leaves. Sennosides act on and irritate the lining of the intestine wall, thereby causing increased intestinal muscle contractions leading to vigorous bowel movement and relief of constipation. Docusate sodium, an anionic surfactant, softens the stool for smoother and easier evacuation.] |
| CD33 Positive | NCIT_C132228 | [Indicates that CD33 expression has been detected in a sample.] |
| Sertraline Hydrochloride | NCIT_C29451 | [The hydrochloride salt of sertraline, a synthetic derivative of naphthalenamine with anti-serotoninergic and anti-depressant properties. Sertraline appears to selectively inhibit the neuronal uptake of serotonin, raising serotonin levels in the CNS.] |
| Selective Serotonin Reuptake Inhibitor | NCIT_C94725 | [Any agent that increases the extracellular level of the neurotransmitter serotonin (5-HT) by inhibiting its reuptake into the presynaptic cell. Increased level in the synaptic cleft prolongs the action of 5-HT on the postsynaptic receptor. This type of agent is typically used as an antidepressant and in the treatment of anxiety disorders and some personality disorders. They are also typically effective and used in treating some cases of insomnia.] |
| RAS Family Gene Mutation | NCIT_C132229 | [A change in the nucleotide sequence in a RAS family gene (HRAS, KRAS or NRAS).] |
| Silenafil Citrate | NCIT_C29452 | |
| Simethicone | NCIT_C29453 | [A mixture of polydimethylsiloxanes with antifoaming and anti-bloating effects. Simethicone reduces the surface tension of gas bubbles causing them to coalesce into larger bubbles that can be passed more easily by belching or flatulence.] |
| Simvastatin | NCIT_C29454 | [A lipid-lowering agent derived synthetically from a fermentation product of the fungus Aspergillus terreus. Hydrolyzed in vivo to an active metabolite, simvastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which catalyzes the conversion of HMG-CoA to mevalonate, a key step in cholesterol synthesis. This agent lowers plasma cholesterol and lipoprotein levels, and modulates immune responses by suppressing MHC II (major histocompatibility complex II) on interferon gamma-stimulated, antigen-presenting cells such as human vascular endothelial cells. (NCI04)] |